Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival.

Yaxiong TangLede LinYunfei XiaoLinghao MengYujia YangXiang Li

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)

MIBC patients may not be carefully evaluated prior to TMT, and some non-ideal candidates underwent TMT. TMT resulted in worse CSS and OS in the contemporary era, but these results may be biased. Strict TMT candidate criteria and TMT treatment modality should be required.

Keyphrases

muscle invasive bladder cancer
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
replacement therapy
combination therapy
cell therapy